PRESS RELEASE published on 04/18/2024 at 13:27, 1 year 9 months ago Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments Evotec SE and Variant Bio partner to discover and develop fibrosis treatments, leveraging cutting-edge genomic discovery platforms. Agreement includes research funding and milestone/royalty payments Evotec SE Research Funding Variant Bio Genomic Discovery Fibrosis Treatments
BRIEF published on 04/17/2024 at 15:05, 1 year 9 months ago Evotec SE Set to Announce 2023 Fiscal Year Results Financial Results Life Sciences Evotec SE Fiscal Year 2023 Stakeholder Engagement
BRIEF published on 04/17/2024 at 15:05, 1 year 9 months ago Evotec SE s'apprête à annoncer ses résultats pour l'exercice 2023 Résultats Financiers Evotec SE Exercice 2023 Sciences De La Vie Engagement Des Parties Prenantes
PRESS RELEASE published on 04/17/2024 at 15:00, 1 year 9 months ago Evotec SE to announce results for fiscal year 2023 on 24 April 2024 Evotec SE will announce its financial results for 2023 with a conference call on 24 April 2024. The company focuses on developing therapeutics through a unique business model Financial Results Conference Call Evotec SE Therapeutics Business Model
BRIEF published on 04/17/2024 at 07:35, 1 year 9 months ago Evotec Appoints Aurélie Dalbiez as Chief People Officer Chief People Officer Human Resources Corporate Leadership Evotec Aurélie Dalbiez
BRIEF published on 04/17/2024 at 07:35, 1 year 9 months ago Evotec nomme Aurélie Dalbiez au poste de Chief People Officer Ressources Humaines Evotec Direction D'entreprise Aurélie Dalbiez Directeur Des Ressources Humaines
PRESS RELEASE published on 04/17/2024 at 07:30, 1 year 9 months ago Evotec welcomes Aurélie Dalbiez as Chief People Officer Evotec SE appoints Aurélie Dalbiez as Chief People Officer, bringing extensive HR leadership experience to drive organizational transformation and employee engagement Chief People Officer Evotec SE Human Resources Aurélie Dalbiez Organizational Transformation
BRIEF published on 03/06/2024 at 07:35, 1 year 11 months ago Evotec and Claris Ventures Partner to Accelerate Biotech Clinical Programs Evotec SE Claris Ventures Biotech Clinical Development IAMA Therapeutics Drug Development Partnership
BRIEF published on 03/06/2024 at 07:35, 1 year 11 months ago Evotec et Claris Ventures s'associent pour accélérer les programmes cliniques de biotechnologie Evotec SE Claris Ventures Développement Clinique Biotechnologique IAMA Thérapeutique Partenariat Pour Le Développement De Médicaments
PRESS RELEASE published on 03/06/2024 at 07:30, 1 year 11 months ago Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic. Evotec and Claris announce acceleration framework to support biotech companies with clinical trials Clinical Trials Claris Ventures Evotec Acceleration Framework Biotech Companies
Published on 02/10/2026 at 22:50, 1 hour 26 minutes ago Tectonic Metals Announces Financing of up to $40 Million
Published on 02/10/2026 at 22:15, 2 hours 1 minute ago Earthwise Minerals Completes Private Placement and Makes Changes to the Management Team
Published on 02/10/2026 at 15:30, 8 hours 46 minutes ago Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/10/2026 at 15:00, 9 hours 16 minutes ago Haven Safety AI Launches AI-Native Safety Intelligence Platform Co-Founded with The AES Corporation and AI Fund
Published on 02/10/2026 at 23:33, 42 minutes ago EQS-Adhoc: All for One Group SE: resolves on a public share buyback offer for up to 2.3% of the share capital and proposes to the Annual General Meeting an amended appropriation of retained earnings
Published on 02/10/2026 at 22:51, 1 hour 25 minutes ago Gerresheimer AG reschedules publication of annual and consolidated financial statements for 2025 and initiates sale of Centor Inc.
Published on 02/10/2026 at 22:28, 1 hour 47 minutes ago EQS-Adhoc: Gerresheimer AG reschedules publication of annual and consolidated financial statements for 2025 and initiates sale of Centor Inc.
Published on 02/10/2026 at 19:07, 5 hours 9 minutes ago Wacker Neuson Group publishes preliminary financial year 2025 figures and shows a positive outlook
Published on 02/10/2026 at 19:06, 5 hours 10 minutes ago EQS-Adhoc: Wacker Neuson Group publishes preliminary financial year 2025 figures
Published on 02/10/2026 at 18:24, 5 hours 51 minutes ago Mersen: Number of shares and voting rights as of January 31, 2026
Published on 02/10/2026 at 18:24, 5 hours 51 minutes ago Mersen : nombre d'actions et de droits de vote au 31 janvier 2026
Published on 02/10/2026 at 18:00, 6 hours 16 minutes ago CIS remporte plusieurs contrats stratégiques en Afrique, en Amérique du Sud et en Asie
Published on 02/10/2026 at 18:00, 6 hours 16 minutes ago CIS wins several strategic contracts in Africa, South America and Asia